Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-mx8w7 Total loading time: 0 Render date: 2025-08-11T00:09:05.470Z Has data issue: false hasContentIssue false

Chapter 3 - Individualized Oocyte Maturation

Published online by Cambridge University Press:  12 February 2021

By
Gustavo Nardini Cecchino ,
Diego Ventura Tarasconi  and
Juan Antonio García Velasco
Edited by
Human M. Fatemi  and
Barbara Lawrenz
Human M. Fatemi
Affiliation:
IVI Middle East Fertility Clinic, Abu Dhabi, UAE
Barbara Lawrenz
Affiliation:
IVI Middle East Fertility Clinic, Abu Dhabi, UAE
Get access

Summary

In vitro fertilization (IVF) outcomes are strongly correlated with the number of mature oocytes retrieved following controlled ovarian stimulation (COS) (). Cumulative live birth rates continuously increase with the number of oocytes available, irrespective of the patient’s age (). Multiple factors may influence the number of oocytes to be fertilized, such as the use of individualized stimulation protocols, patient compliance and the ovulation trigger (OT) strategy.

Information

Type
Chapter
Information
Individualized In-Vitro Fertilization
Delivering Precision Fertility Treatment
 , pp. 30 - 38
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Sunkara, SK, Rittenberg, V, Raine-Fenning, N, et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011;26:1768–1774.CrossRefGoogle ScholarPubMed
Polyzos, NP, Drakopoulos, P, Parra, J, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril 2018;110:661–670.CrossRefGoogle Scholar
Conti, M, Hsieh, M, Musa Zamah, A, et al. Novel signaling mechanisms in the ovary during oocyte maturation and ovulation. Mol Cell Endocrinol 2012;356:65–73.CrossRefGoogle ScholarPubMed
Eppig, JJ. FSH stimulates hyaluronic acid synthesis by oocyte-cumulus cell complexes from mouse preovulatory follicles. Nature 1979;281:483–484.CrossRefGoogle ScholarPubMed
Andersen, CY, Leonardsen, L, Ulloa-Aguirre, A, et al. FSH-induced resumption of meiosis in mouse oocytes: Effect of different isoforms. Mol Hum Reprod 1999;5:726–731.CrossRefGoogle Scholar
Seibel, MM, Smith, DM, Levesque, L, et al. The temporal relationship between the luteinizing hormone surge and human oocyte maturation. Am J Obstet Gynecol 1982;142:568–572.CrossRefGoogle ScholarPubMed
Eppig, JJ. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. In: Reproduction, Fertility and Development. CSIRO, 1996:485–489.Google Scholar
Scott, RT, Hofmann, GE, Muasher, SJ, et al. Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration. J Vitr Fertil Embryo Transf 1989;6:73–75.CrossRefGoogle ScholarPubMed
Dosouto, C, Haahr, T, Humaidan, P. Advances in ovulation trigger strategies. Panminerva Med 2019;61:42–51.CrossRefGoogle ScholarPubMed
Castillo, JC, Humaidan, P, Bernabéu, R. Pharmaceutical options for triggering of final oocyte maturation in ART. BioMed Res Int 2014. doi:10.1155/2014/580171. [Epub ahead of print]CrossRefGoogle Scholar
Loumaye, E, Engrand, P, Arguinzoniz, M, et al. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: Results of a multicenter double-blind study. J Clin Endocrinol Metab 2001;86:2607–2618.Google Scholar
Casarini, L, Santi, D, Brigante, G, et al. Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG. Endocrine Rev 2018;39:549–592.Google Scholar
Huhtaniemi, IT, Catt, KJ. Differential binding affinities of rat testis luteinizing hormone (lH) receptors for human chorionic gonadotropin, human lH, and ovine LH. Endocrinology 1981;108:1931–1938.CrossRefGoogle ScholarPubMed
Huhtaniemi, IT, Clayton, RN, Catt, KJ. Gonadotropin binding and leydig cell activation in the rat testis in vivo. Endocrinology 1982;111:982–987.CrossRefGoogle ScholarPubMed
Youssef, MA, Abou-Setta, AM, Lam, WS. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev 2016. doi:10.1002/14651858.CD003719.pub4. [Epub ahead of print]Google Scholar
Gonen, Y, Balakier, H, Powell, W, et al. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990;71:918–922.CrossRefGoogle ScholarPubMed
Dosouto, C, Haahr, T, Humaidan, P. Gonadotropin-releasing hormone agonist (GnRHa) trigger – state of the art. Reprod Biol 2017;17:1–8.CrossRefGoogle ScholarPubMed
Itskovitz, J, Boldes, R, Levron, J, et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 1991;56:213–220.CrossRefGoogle ScholarPubMed
Griesinger, G, Diedrich, K, Devroey, P, et al. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006;12:159–168.CrossRefGoogle ScholarPubMed
Kolibianakis, EM, Schultze-Mosgau, A, Schroer, A, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 2005;20:2887–2892.CrossRefGoogle ScholarPubMed
Haahr, T, Roque, M, Esteves, SC, et al. GnRH agonist trigger and LH activity luteal phase support versus hcg trigger and conventional luteal phase support in fresh embryo transfer IVF/ICSI cycles-a systematic PRISMA review and meta-analysis. Front Endocrinol 2017;8. doi:10.3389/fendo.2017.00116. [Epub ahead of print]CrossRefGoogle ScholarPubMed
Youssef, MAFM, Van der Veen, F, Al-Inany, HG, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev 2014. doi:10.1002/14651858.CD008046.pub4. [Epub ahead of print]CrossRefGoogle Scholar
Shapiro, BS, Daneshmand, ST, Restrepo, H, et al. Efficacy of induced luteinizing hormone surge after “trigger” with gonadotropin-releasing hormone agonist. Fertil Steril 2011;95:826–828.Google Scholar
Fabris, AM, Cruz, M, Legidos, V, et al. Dual triggering with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin in patients with a high immature oocyte rate. Reprod Sci 2017;24:1221–1225.CrossRefGoogle ScholarPubMed
De Oliveira, SA, Calsavara, VF, Cortés, GC. Final oocyte maturation in assisted reproduction with human chorionic gonadotropin and gonadotropin-releasing hormone agonist (dual trigger). J Bras Reprod Assist 2016;20:246–250.CrossRefGoogle Scholar
Haas, J, Zilberberg, E, Dar, S, et al. Co-administration of GnRH agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report. J Ovarian Res 2014;7. doi:10.1186/1757-2215-7-77. [Epub ahead of print]CrossRefGoogle ScholarPubMed
Orvieto, R. Triggering final follicular maturation-hCG, GnRH agonist or both, when and to whom? J Ovarian Res 2015;8:60.CrossRefGoogle ScholarPubMed
Beck-Fruchter, R, Weiss, A, Lavee, M, et al. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod 2012;27:1357–1367.CrossRefGoogle Scholar
Haas, J, Ophir, L, Barzilay, E, et al. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study. Fertil Steril 2016;106:653–659.CrossRefGoogle ScholarPubMed
Ben-Ami, I, Komsky, A, Bern, O, et al. In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium. Hum Reprod 2011;26:76–81.CrossRefGoogle ScholarPubMed
Peluso, JJ. Role of the amplitude of the gonadotropin surge in the rat. Fertil Steril 1990;53:150–154.Google Scholar
Meyer, L, Murphy, LA, Gumer, A, et al. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles. Fertil Steril 2015;104:637–642.CrossRefGoogle ScholarPubMed
Chen, SL, Ye, DS, Chen, X, et al. Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol. Hum Reprod 2012;27:1351–1356.CrossRefGoogle ScholarPubMed
Cozzolino, M, Matey, S, Alvarez, A, Toribio, M, López, V, Perona, M, Henzenn, E, Piró, M, Humaidan, P, Garcia-Velasco, JA. Self-detection of the LH surge in urine after GnRH agonist trigger in IVF – how to minimize failure to retrieve oocytes. Front Endocrinol 2020;11:221.CrossRefGoogle ScholarPubMed
Lu, X, Hong, Q, Sun, LH, et al. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Fertil Steril 2016;106:1356–1362.CrossRefGoogle ScholarPubMed
Rosen, MP, Zamah, AM, Shen, S, et al. The effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery. Reprod Biol Endocrinol 2009;7. doi:10.1186/1477-7827-7-35. [Epub ahead of print]CrossRefGoogle ScholarPubMed
Lamb, JD, Shen, S, McCulloch, C, et al. Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2011;95:1655–1660.CrossRefGoogle ScholarPubMed
Castillo, JC, García-Velasco, J, Humaidan, P. Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. J Assist Reprod Genet 2012;29:249–253.CrossRefGoogle ScholarPubMed
Blazquez, A, Guillén, JJ, Colomé, C, et al. Empty follicle syndrome prevalence and management in oocyte donors. Hum Reprod 2014;29:2221–2227.Google Scholar
Ben-Shlomo, I, Schiff, E, Levran, D, et al. Failure of oocyte retrieval during in vitro fertilization: a sporadic event rather than a syndrome. Fertil Steril 1991;55:324–327.CrossRefGoogle ScholarPubMed
Zegers-Hochschild, F, Fernández, E, Mackenna, A, et al. The empty follicle syndrome: a pharmaceutical industry syndrome. Hum Reprod 1995;10:2262–2265.CrossRefGoogle ScholarPubMed
Zreik, TG, García-Velasco, J, Vergara, T, et al. Empty follicle syndrome: evidence for recurrence. Hum Reprod 2000;15:999–1002.CrossRefGoogle ScholarPubMed
Ajonuma, LC. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyperstimulation syndrome (OHSS)? Med Hypotheses 2008;70:1174–1178.CrossRefGoogle ScholarPubMed
Cerrillo, M, Pacheco, A, Rodríguez, S, et al. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertil Steril 2011;95:2517–2519.CrossRefGoogle ScholarPubMed

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×